Macro1 domain residue F156: A hallmark of SARS-CoV-2 de-MARylation specificity

Oney Ortega Granda1, Karine Alvarez1, Maria J Mate-Perez1

  • 1Aix Marseille Université, CNRS, AFMB UMR 7257, Marseille, France.

Virology
|July 30, 2023
PubMed

Insights

This study investigates the SARS-CoV-2 nsp3 protein's Macro1 domain, crucial for regulating innate immunity. Mutational analysis reveals specific residues significantly impact ADP-ribose binding and de-MARylation activity, affecting viral interactions with host defenses.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an RNA virus encoding non-structural proteins, including nsp3.
  • The nsp3 protein contains a conserved Macro1 domain involved in ADP-ribosylation.
  • Viral Macro domains bind to ADP-ribose moieties and possess hydrolase activity regulating innate immunity and interferon responses.

Purpose of the Study:

  • To investigate the role of specific amino acid residues in the SARS-CoV-2 nsp3 Macro1 domain.
  • To elucidate the impact of mutations on ADP-ribose binding and de-MARylation activity.
  • To understand differences in host interferon response regulation between SARS-CoV-2 and SARS-CoV.

Main Methods:

  • Bioinformatic and structural analyses to identify key residues (F156 in SARS-CoV-2, N157 in SARS-CoV).
  • Site-directed mutagenesis to create alanine substitutions at these key positions.
  • Biochemical assays to assess ADP-ribose binding and de-MARylation (hydrolysis) activity.

Main Results:

  • Mutations slightly altered ADP-ribose binding affinity.
  • Alanine substitution at F156 in SARS-CoV-2 abolished de-MARylation activity.
  • The same substitution in SARS-CoV reduced de-MARylation activity by 70% and hampered poly-ADP-ribose binding.

Conclusions:

  • The investigated residues are critical for the de-MARylation function of the nsp3 Macro1 domain.
  • Differences in these residues may contribute to the distinct host interferon responses induced by SARS-CoV-2 and SARS-CoV.
  • Targeting these enzymatic activities could offer therapeutic strategies against coronaviruses.